DUBLIN, September 22, 2022 /PRNewswire/ — Added CBRN Defense – Global Market Trajectory & Analytics report ResearchAndMarkets.com Offer.
Rated market size at $20.8 billion to 2026, it is a healthy outlook for the global CBRN defense market
Amid the COVID-19 crisis, the global CBRN Defense market is estimated at $16.7 billion in 2022 is expected to reach a revised size of $20.8 billion to 2026 and growing at a CAGR of 5.8% over the analysis period.
Chemicals, one of the segments analyzed in the report, is expected to grow at a CAGR of 6.7%, while growth in the Radiology segment is adjusted to a revised CAGR of 6.1%. Biological warfare is real and a confusing threat to the world as various countries, including the US, Russia and Chinahave the impression that they are quietly working on biological weapons and even keep an inventory.
Depending on the pathogen, route of inoculation, size and immune system of the affected person, these microorganisms have an incubation period of a few days to a few weeks. Biological weapons can lead to catastrophic, large-scale epidemics and serious medical complications or fatalities.
Biological warfare is a matter of serious concern because the technology involved in making these weapons is comparatively affordable and easily accessible. In addition, microorganisms necessary for the development of most biological warfare agents are readily available.
Acquisition along with the distribution of some of the restricted organisms such as Variola major is possible. It is extremely difficult to keep track of biological weapons development in all countries because the production units associated with the approach take up little space and are difficult to identify.
Biological weapons have attracted various countries, organizations, groups, and individuals over the past several decades. Various countries have reported a number of biological terrorism-related acts over the past few decades, including a sarin nerve agent attack in Japan 1995 along with failed attempts to kill thousands of people.
Countries like the US and Russia They are expected to hold frozen stocks of highly contagious biological warfare agents known to cause incurable diseases such as anthrax. Deliberate or accidental access to these biological weapons by terrorists or renegade politicians can have catastrophic results.
There are serious concerns about certain stocks of traditional biological warfare agents such as Ebola, anthrax and typhoid. On the other hand, various countries have devoted research and other resources to the development of genetically modified organisms. While several countries like Iraq allegedly in possession of bioweapons, there is a serious threat from terrorist organizations who can misuse these weapons to create an uncontrollable epidemic.
Anthrax remains the most popular choice for the majority of biological warfare programs due to the bacterium’s ability to create deadly spores. Inhaling these spores in certain amounts can lead to a medical condition that is fatal and requires urgent treatment with significant doses of a specific penicillin-type antibiotic.
While traditional biological warfare agents such as smallpox and anthrax pose serious threats, various countries are looking beyond these options and taking advantage of black biology. The concept of black biology revolves around the development of genetically engineered microorganisms that can be used as biological weapons.
Technology focuses on inserting specific genes into DNA for good or malicious purposes. The concept has serious implications as genetic maps of various deadly microorganisms such as bacteria and viruses are publicly available and can be used to develop biological weapons.
Researchers recently published the entire genetic code of the cholera pathogen. In addition, the research community is striving to map the genomes of a large number of microbes, such as B. the bacteria associated with plague, anthrax and typhoid fever. The information can be used to develop clones of highly virulent strains of viruses and bacteria.
Additionally, misguided microbiologists can be exploited by unscrupulous customers to create incurable designer options like penicillin-resistant anthrax and viruses that can cause infections while they remain silent.
Russia claimed that Ukraine and the US are working in various laboratories with pathogens known to cause serious infections. Ukraine has several public health laboratories engaged in research and development to find solutions to deal with dangerous infections. Some of these laboratories receive financial and other support from the EU and the US. Russia’s claims are based in part on the Biological Threat Reduction Program introduced by the US in the 1990s to mitigate the risk associated with biological weapons left in various countries, such as Ukraine.
The program provides US financial support for equipment and modernization. In addition, the US Department of Defense has worked collaboratively Ukraine for improving public health laboratories since 2005. The US also offers technical assistance Ukraine and other countries to deal with outbreaks of multiple infectious diseases.
The US claims that these efforts are aimed more at mitigating the serious threat posed by the proliferation of biological weapons than at developing such weapons. On the other hand, Russian officials claim so Ukraine attempts to obfuscate the evidence of prohibited activities while at the same time making efforts to destroy bio-agents in various laboratories.
Despite questions about the authenticity of these claims, such claims are confusing and have brought the focus back to chemical and biological warfare. The presence of biological weapons could further escalate the conflict and raise serious concerns about the misuse of such weapons.
The scenario offers lucrative opportunities for the growth of CBRN defenses, defined as defense equipment and technologies used against chemical weapons or biological pathogens. CBRN surveillance and countermeasures include the advancement of sensor technologies to detect airborne materials and deposited pollutants. CBRN draws expertise from information and computer systems, engineering, physics and chemistry, enabling end-to-end technology advances.
What’s new for 2022?
- Global competitiveness and percentage market shares of key competitors
- Market Presence in Multiple Regions – Strong/Active/Niche/Trivial
- Interactive online peer-to-peer collaborative customized updates
- Access to the digital archive
- Free updates for one year
Main topics covered:
1. MARKET OVERVIEW
- As the threat of biological and chemical warfare becomes real, CBRN countermeasures are taking the spotlight due to an increased focus on preparedness and response
- Russian allegations of biological weapons activity in Ukraine Brings this hidden but ever-present threat back into the spotlight
- Concerns about geopolitical strife and runaway inflation are overtaking worries about the now-declining COVID-19 pandemic
- Competitive Market Presence – Strong/Active/Niche/Trivial for 83 players worldwide in 2022 (E)
- What are biological, chemical and radioactive weapons? How do we prepare to protect against them and what is the role of CBRN defenses?
- The pandemic is failing to deter global military spending, which will surge to an all-time high in 2021, a sign of good times to prevail for CBRN defences
- Current market activity
2. FOCUS ON SELECTED PLAYERS (total 83 recommended)
- AirBoss of America Corp.
- Argon Electronics Ltd.
- Avon Protection Systems, Inc.
- Bluecher GmbH
- Bruker Corporation
- Chemring Group PLC
- Cristani Spa
- Environics Oy
- FLIR Systems, Inc.
- Karcher Futuretech GmbH
- MSA Safety, Inc.
- Smiths Group PLC
- Thales Group
3. MARKET TRENDS & DRIVERS
- As the world ramps up military spending in the wake of the Russia-Ukraine war, CBRN defense solutions are poised to capitalize on the unfortunate state of global geopolitical affairs
- Allegations of the alleged use of chemical and biological weapons in the Russia-Ukraine war are putting this dirty war strategy back in the spotlight
- Increasing conflicts in the South China Sea are expected to boost growth in the Asian market
- Increased activities on the front lines of nuclear decommissioning increase the need for radiation protection and emergency training during nuclear decommissioning
- The limited success of global efforts to stem the spread of biological, chemical and radioactive weapons drives the need for preparedness and response for CBRN countermeasures
- An overview of the many reasons the military is increasing its focus on equipping infantry with CBRN training devices
- Radiation protection training storms into the limelight
- Special focus on CBRN and HazMat training
- COVID-19 increases focus on the use of simulators for CBRN training
- Increased emphasis on safety in CBRNE training
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
For more information about this report, visit https://www.researchandmarkets.com/r/jv9w4g
research and markets
Laura WoodSenior managers
For EST office hours, call +1-917-300-0470
For US/CAN, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900
US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716
SOURCE Research and Markets